Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial

PURPOSE: Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional failure (LRF) rates after definitive chemoradiation (CRT), associated with anogenital human papilloma virus, and often appears in HIV infection. Because cetuximab enhances the effect of radiation therapy...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Sparano, Joseph A., Lee, Jeannette Y., Palefsky, Joel, Henry, David H., Wachsman, William, Rajdev, Lakshmi, Aboulafia, David, Ratner, Lee, Fitzgerald, Thomas J., Kachnic, Lisa, Mitsuyasu, Ronald
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2017
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455422/
https://ncbi.nlm.nih.gov/pubmed/27937092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.69.1642
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker